Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Travere Therapeutics
Pharma
EU regulator says yes to Tavere's Filspari, several other meds
Along with other positive recommendations, Europe's drug regulators rendered a positive opinion on Travere's Filspari for full approval in IgAN.
Kevin Dunleavy
Feb 23, 2024 12:12pm
FDA grants Calliditas full nod for kidney disease drug Tarpeyo
Dec 20, 2023 5:24pm
Travere cuts 20% of workforce, aims to win full nod for Filspari
Dec 5, 2023 11:26am
Travere looks to consistent benefit to stay in kidney disease
Nov 3, 2023 10:34am
Travere's Filspari misses the mark in rare kidney disease trial
Sep 21, 2023 2:32pm
Mirum ponies up $445M for 2 Travere liver disease drugs
Jul 18, 2023 8:00am